VNDA 8-K: Legal settlement

Vanda Pharmaceuticals

Filed with the SEC on · accession 0001628280-26-075166

VNDA filed a 8-K (current report) with the SEC on Nov 20, 2026. Vanda Pharmaceuticals entered into a Confidential Settlement and License Agreement with MSN Pharmaceuticals and MSN Laboratories to resolve patent infringement litigation over MSN's generic version of HETLIOZ LQ (tasimelteon oral suspension).

Summary of the filing

Vanda Pharmaceuticals entered into a Confidential Settlement and License Agreement with MSN Pharmaceuticals and MSN Laboratories to resolve patent infringement litigation over MSN's generic version of HETLIOZ LQ (tasimelteon oral suspension). Under the agreement, MSN received a royalty-free license to market its generic in the U.S. beginning in the first quarter of 2040, with limited pre-launch rights and possible earlier market entry under certain conditions.

Key details

Registrant, patent owner, licensorVanda Pharmaceuticals Inc.
Settling party, licenseeMSN Pharmaceuticals Inc.
Settling party, licenseeMSN Laboratories Private Limited
Senior vice president, general counsel and secretaryDaniel McGuire

✦ Ask GOAX AI about this filing — what it means for VNDA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VNDA?

Click here

Frequently asked questions

What did VNDA file with the SEC on Nov 20, 2026?

VNDA filed a 8-K (Legal settlement). Vanda Pharmaceuticals entered into a Confidential Settlement and License Agreement with MSN Pharmaceuticals and MSN Laboratories to resolve patent infringement litigation over MSN's generic version of HETLIOZ LQ (tasimelteon oral suspension). Under the agreement, MSN received a royalty-free license to market its generic in the U.S. beginning in the first quarter of 2040, with limited pre-launch rights and possible earlier market entry under certain conditions.

What does a legal settlement mean for VNDA stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other VNDA SEC filings

Get alerts when VNDA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days